390 related articles for article (PubMed ID: 23852922)
1. Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease.
Mesulam MM
J Comp Neurol; 2013 Dec; 521(18):4124-44. PubMed ID: 23852922
[TBL] [Abstract][Full Text] [Related]
2. Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
Lin CP; Frigerio I; Boon BDC; Zhou Z; Rozemuller AJM; Bouwman FH; Schoonheim MM; van de Berg WDJ; Jonkman LE
Brain; 2022 Aug; 145(8):2869-2881. PubMed ID: 35259207
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.
Zhu QB; Unmehopa U; Bossers K; Hu YT; Verwer R; Balesar R; Zhao J; Bao AM; Swaab D
Brain; 2016 Mar; 139(Pt 3):908-21. PubMed ID: 26792551
[TBL] [Abstract][Full Text] [Related]
4. Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey.
Mesulam MM; Mufson EJ
Brain; 1984 Mar; 107 ( Pt 1)():253-74. PubMed ID: 6538106
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
Schumacher J; Ray NJ; Hamilton CA; Donaghy PC; Firbank M; Roberts G; Allan L; Durcan R; Barnett N; O'Brien JT; Taylor JP; Thomas AJ
Brain; 2022 Jun; 145(5):1773-1784. PubMed ID: 34605858
[TBL] [Abstract][Full Text] [Related]
6. Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology.
Cullen KM; Halliday GM
Neurobiol Aging; 1998; 19(4):297-306. PubMed ID: 9733161
[TBL] [Abstract][Full Text] [Related]
7. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease.
Arendt T; Bigl V; Tennstedt A; Arendt A
Neuroscience; 1985 Jan; 14(1):1-14. PubMed ID: 3974875
[TBL] [Abstract][Full Text] [Related]
8. The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer's Disease.
Bekdash RA
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525357
[TBL] [Abstract][Full Text] [Related]
9. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
[TBL] [Abstract][Full Text] [Related]
10. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
[TBL] [Abstract][Full Text] [Related]
11. Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease.
Cullen KM; Halliday GM; Double KL; Brooks WS; Creasey H; Broe GA
Neuroscience; 1997 Jun; 78(3):641-52. PubMed ID: 9153647
[TBL] [Abstract][Full Text] [Related]
12. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease.
Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K
Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177
[TBL] [Abstract][Full Text] [Related]
14. Gene and cell therapy for the nucleus basalis of Meynert with NGF in Alzheimer's disease.
Eriksdotter M; Mitra S
Handb Clin Neurol; 2021; 179():219-229. PubMed ID: 34225964
[TBL] [Abstract][Full Text] [Related]
15. Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease.
Morawski M; Hartlage-Rübsamen M; Jäger C; Waniek A; Schilling S; Schwab C; McGeer PL; Arendt T; Demuth HU; Rossner S
Acta Neuropathol; 2010 Aug; 120(2):195-207. PubMed ID: 20383514
[TBL] [Abstract][Full Text] [Related]
16. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.
Arendt T; Bigl V; Arendt A; Tennstedt A
Acta Neuropathol; 1983; 61(2):101-8. PubMed ID: 6637393
[TBL] [Abstract][Full Text] [Related]
17. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei--potential implication for arousal and attention.
Sauvage M; Steckler T
Neuroscience; 2001; 104(3):643-52. PubMed ID: 11440798
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.
Mesulam M; Shaw P; Mash D; Weintraub S
Ann Neurol; 2004 Jun; 55(6):815-28. PubMed ID: 15174015
[TBL] [Abstract][Full Text] [Related]
19. Some cholinergic themes related to Alzheimer's disease: synaptology of the nucleus basalis, location of m2 receptors, interactions with amyloid metabolism, and perturbations of cortical plasticity.
Mesulam MM
J Physiol Paris; 1998; 92(3-4):293-8. PubMed ID: 9789826
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co-localization with cholinergic neurons.
Mufson EJ; Presley LN; Kordower JH
Brain Res; 1991 Jan; 539(1):19-30. PubMed ID: 1849779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
